[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Actuate Therapeutics [@ActuateThera](/creator/twitter/ActuateThera) on x XX followers Created: 2025-07-18 16:45:14 UTC “We are highly encouraged by the responses observed in refractory and resistant Ewing Sarcoma , a disease where treatment options are extremely limited beyond frontline chemotherapy,” said Daniel Schmitt, President & CEO of Actuate. Learn more: $ACTU  XXX engagements  **Related Topics** [$actu](/topic/$actu) [$fro](/topic/$fro) [Post Link](https://x.com/ActuateThera/status/1946249916910543306)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Actuate Therapeutics @ActuateThera on x XX followers
Created: 2025-07-18 16:45:14 UTC
“We are highly encouraged by the responses observed in refractory and resistant Ewing Sarcoma , a disease where treatment options are extremely limited beyond frontline chemotherapy,” said Daniel Schmitt, President & CEO of Actuate. Learn more: $ACTU
XXX engagements
/post/tweet::1946249916910543306